Acadia Pharmaceuticals Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$2
Book Value Per Share
$7
Free Cash Flow Per Share
$1
Cash Per Share
$1
Revenue Per Share
$6
OCF Per Share
$1
Return on Equity
39.9%
Return on Assets
28.4%
Return on Invested Capital
10.7%
Current Ratio
3.83
Quick Ratio
3.43
Asset Turnover
0.78
Days Sales Outstanding
41.37
Days Payables Outstanding
44.72
Days Inventory On Hand
456.77
Cash Conversion Cycle
453.43
R&D / Revenue
30.7%
SBC / Revenue
4.9%
Capex / Revenue
0.4%
Working Capital
$785M
Net Current Asset Value
$725M
Invested Capital
$1.23B
OCF / Net Income
0.28
FCF / Net Income
0.27
Accruals Ratio (Sloan)
18.0%
Net Debt
$-178M
Net Debt / EBITDA
-1.68
Interest Coverage
3.30
Cash Coverage
3.46
Capex Coverage
23.42
Tangible Common Equity
$1.12B
TCE / Total Assets
71.5%
NOPAT
$105M
Cash ROIC
10.7%
WC / Revenue
73.3%
Capex / D&A
5.38
Reinvestment Rate
3.6%
Asset Growth vs Revenue Growth
19.8%
Revenue 5Y CAGR
19.4%
Book Value 5Y CAGR
14.4%
Stock Price (FY-end)
$27
Market Cap
$4.54B
P/E Ratio
11.61
P/S Ratio
4.24
P/B Ratio
3.70
P/TB Ratio
4.06
P/OCF Ratio
41.32
P/FCF Ratio
43.16
Enterprise Value
$4.36B
EV / EBITDA
41.26
EV / Sales
4.07
EV / FCF
41.47
FCF Yield
2.3%
Shareholder Yield
-1.1%
R&D Yield
7.2%
Capex Yield
0.1%
Operating Leverage
-4.60
Graham Number
$19
Shares Variation (YoY)
2.1%
Beta (5Y)
0.94
Cost of Equity
9.2%
52W High
$28
52W Low
$14
Trailing Return 1Y
57.6%
Trailing Return 5Y
-51.5%
F-Score (Piotroski)
5.00
Z-Score (Altman)
7.97
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.